1. Home
  2. SABS vs AIRI Comparison

SABS vs AIRI Comparison

Compare SABS & AIRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SABS
  • AIRI
  • Stock Information
  • Founded
  • SABS 2014
  • AIRI 1979
  • Country
  • SABS United States
  • AIRI United States
  • Employees
  • SABS N/A
  • AIRI N/A
  • Industry
  • SABS Biotechnology: Pharmaceutical Preparations
  • AIRI Military/Government/Technical
  • Sector
  • SABS Health Care
  • AIRI Industrials
  • Exchange
  • SABS Nasdaq
  • AIRI Nasdaq
  • Market Cap
  • SABS 15.8M
  • AIRI 13.4M
  • IPO Year
  • SABS N/A
  • AIRI N/A
  • Fundamental
  • Price
  • SABS $1.76
  • AIRI $3.35
  • Analyst Decision
  • SABS Strong Buy
  • AIRI
  • Analyst Count
  • SABS 5
  • AIRI 0
  • Target Price
  • SABS $11.80
  • AIRI N/A
  • AVG Volume (30 Days)
  • SABS 17.6K
  • AIRI 40.6K
  • Earning Date
  • SABS 08-07-2025
  • AIRI 08-13-2025
  • Dividend Yield
  • SABS N/A
  • AIRI N/A
  • EPS Growth
  • SABS N/A
  • AIRI N/A
  • EPS
  • SABS N/A
  • AIRI N/A
  • Revenue
  • SABS $377,835.00
  • AIRI $53,182,000.00
  • Revenue This Year
  • SABS N/A
  • AIRI $5.59
  • Revenue Next Year
  • SABS N/A
  • AIRI $5.00
  • P/E Ratio
  • SABS N/A
  • AIRI N/A
  • Revenue Growth
  • SABS N/A
  • AIRI 0.29
  • 52 Week Low
  • SABS $1.00
  • AIRI $3.00
  • 52 Week High
  • SABS $5.01
  • AIRI $9.44
  • Technical
  • Relative Strength Index (RSI)
  • SABS 48.13
  • AIRI 46.91
  • Support Level
  • SABS $1.69
  • AIRI $3.33
  • Resistance Level
  • SABS $1.87
  • AIRI $3.55
  • Average True Range (ATR)
  • SABS 0.11
  • AIRI 0.18
  • MACD
  • SABS -0.01
  • AIRI -0.01
  • Stochastic Oscillator
  • SABS 53.45
  • AIRI 17.07

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

About AIRI Air Industries Group

Air Industries Group is an aerospace and defense company. Its manufactures and designs structural parts and assemblies that focus on flight safety, including landing gear, arresting gear, engine mounts, flight controls, throttle quadrants, jet engines, and other components. The company also provides sheet metal fabrication of aerostructures, tube bending, and welding services.

Share on Social Networks: